Achille Panzeri

Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor

Maria Menichincheri, Elena Ardini, Paola Magnaghi et al. · Journal of Medicinal Chemistry · 2016 · 298 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor

Maria Gabriella Brasca, Nadia Amboldi, Dario Ballinari et al. · Journal of Medicinal Chemistry · 2009 · 128 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel aromatase and 5α-reductase inhibitors

E. Di Salle, G. Briatico, D. Giudici et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1994 · 56 citations

Life Sciences, Biochemistry, Pharmacology +14

PNU 157706, a novel dual type I and II5α-reductase inhibitor

E. Di Salle, D. Giudici, Antonella Radice et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1998 · 44 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Identification of Potent Pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamides as Multi-Cyclin-Dependent Kinase Inhibitors

Gabriella Traquandi, Marina Ciomei, Dario Ballinari et al. · Journal of Medicinal Chemistry · 2010 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15